| Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. H Yazici, Y Tüzün, H Pazarli, S Yurdakul, Y Ozyazgan, H Ozdoğan, ... Annals of the rheumatic diseases 43 (6), 783-789, 1984 | 568 | 1984 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 246 | 2019 |
| Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry JP Bassand, S Virdone, SZ Goldhaber, AJ Camm, DA Fitzmaurice, ... Circulation 139 (6), 787-798, 2019 | 76 | 2019 |
| Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019 | 57 | 2019 |
| The relationship between chronic kidney disease and SYNTAX score U Coskun, K Orta Kilickesmez, O Abaci, C Kocas, C Bostan, A Yildiz, ... Angiology 62 (6), 504-508, 2011 | 53 | 2011 |
| N‐acetylcysteine versus N‐acetylcysteine + theophylline for the prevention of contrast nephropathy M Baskurt, B Okcun, O Abaci, GM Dogan, K Kilickesmez, AA Ozkan, ... European journal of clinical investigation 39 (9), 793-799, 2009 | 53 | 2009 |
| Long-term follow-up of patients at high risk for nephropathy after contrast exposure O Abaci, O Harmankaya, B Kocas, C Kocas, C Bostan, U Coskun, A Yildiz, ... Angiology 66 (6), 514-518, 2015 | 47 | 2015 |
| The effect of exercise to P wave dispersion and its evaluation as a predictor of atrial fibrillation Z Yiğit, H Akdur, M Ersanli, B Ökçün, Ö Güven Annals of Noninvasive Electrocardiology 8 (4), 308-312, 2003 | 45 | 2003 |
| Platelet-to-lymphocyte ratio predicts contrast-induced nephropathy in patients with non-ST-segment elevation acute coronary syndrome C Kocas, A Yildiz, O Abaci, OS Karaca, N Firdin, Y Dalgic, C Bostan, ... Angiology 66 (10), 964-968, 2015 | 43 | 2015 |
| Chronic kidney disease as a predictor of coronary lesion morphology KO Kilickesmez, O Abaci, B Okcun, C Kocas, M Baskurt, A Arat, M Ersanli, ... Angiology 61 (4), 344-349, 2010 | 30 | 2010 |
| Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ... Diabetes Care 44 (5), 1219-1227, 2021 | 21 | 2021 |
| Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry JPS Sawhney, VA Kothiwale, V Bisne, R Durgaprasad, P Jadhav, ... Indian heart journal 70 (6), 828-835, 2018 | 21 | 2018 |
| Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists DA Fitzmaurice, G Accetta, S Haas, G Kayani, H Lucas Luciardi, ... British journal of haematology 174 (4), 610-623, 2016 | 19 | 2016 |
| The role of media on statin adherence C Kocas, O Abaci, BB Kocas, G Cetinkal, S Arslan, A Yildiz, M Ersanli International Journal of Cardiology 201, 139, 2015 | 16 | 2015 |
| Güncel ve etkin bir transmitter: nitrik oksit N Gültekin, M Ersanlı, E Küçükateş Türk Kardiyol Dern Arş 24, 311-320, 1996 | 16 | 1996 |
| Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in TURKEY: inferences from GARFIELD-AF registry BY Sayın, S Okutucu, MB Yılmaz, K Özdemir, A Aydınlar, DY Şahin, ... Anatolian Journal of Cardiology 21 (5), 272, 2019 | 15 | 2019 |
| Relationship between serum endothelin-1 level and spontaneous reperfusion in patients with acute myocardial infarction KO Kilickesmez, G Bingöl, L Bulut, ÜY Sinan, O Abaci, M Ersanli, ... Coronary Artery Disease 26 (1), 37-41, 2015 | 15 | 2015 |
| Admission hyperglycemia is associated with failed reperfusion following fibrinolytic therapy in patients with STEMI: results of a retrospective study C Kocas, O Abaci, GS Halil, S Arslan, G Cetinkal, C Bostan, U Coskun, ... American Journal of Cardiovascular Drugs 15, 35-42, 2015 | 14 | 2015 |
| Percutaneous coronary intervention vs. optimal medical therapy–the other side of the coin: medication adherence C Kocas, O Abaci, V Oktay, U Coskun, C Bostan, A Yildiz, AA Ozkan, ... Journal of clinical pharmacy and therapeutics 38 (6), 476-479, 2013 | 14 | 2013 |
| Admission hyperglycemia and TIMI frame count in primary percutaneous coronary intervention A Yildiz, A Arat-Ozkan, C Kocas, O Abaci, U Coskun, C Bostan, A Olcay, ... Angiology 63 (5), 325-329, 2012 | 14 | 2012 |
